The invention relates to the field of medicine and to the chemical and pharmacological industry, and concerns agents for the treatment of cancer. 3-O-Sulfamate 16,16-dimethyl-D-homoequilenin is proposed as an anti-cancer agent in monotherapy and adjuvant therapy of oncological diseases such as hepatocellular carcinoma, gastric carcinoma, lung cancer, chronic myelogenous leukemia, and breast cancer including triple negative breast cancer. The new compound has not any uterotropic activity in animals and does not influence on endometrium.
本发明涉及医学领域以及
化学和制药工业,涉及治疗癌症的药物。建议将 3-O-
氨基磺酸 16,16-二甲基-D-高喹宁作为抗癌剂,用于肝细胞癌、胃癌、肺癌、慢性粒细胞白血病和乳腺癌(包括三阴性乳腺癌)等肿瘤疾病的单药治疗和辅助治疗。这种新化合物对动物没有任何子宫刺激活性,对子宫内膜也没有影响。